Serum uric acid level as a putative biomarker in Parkinson's disease patients carrying GBA1 mutations: 2-Year data from the PPMI study

Blood uric acid represents an important biomarker in sporadic Parkinson ’s disease (PD). Whether uric acid levels change in genetic forms of PD is beginning to be assessed. The aim of the present study was to evaluate differences in serum uric acid level among PD patients harboring mutations in the glucocerebrosidase (GBA1) gene, sporadic PD, and healthy controls foll owed longitudinally.

Source: Parkinsonism and Related Disorders - January 19, 2021 Category: Neurology Authors: Christos Koros, Athina-Maria Simitsi, Nikolaos Papagiannakis, Anastasia Bougea, Andreas Prentakis, Dimitra Papadimitriou, Ioanna Pachi, Roubina Antonelou, Efthalia Angelopoulou, Ion Beratis, Maria Bozi, Sokratis G. Papageorgiou, Xenia Geronicola Trapali, Tags: Short communication Source Type: research